|
| | Univariate analysis | value | Multivariate analysis | value |
|
| Tumor grade (low vs intermediate/high) | HR 4.798 (95% CI 1.128–20.145) | 0.019 | HR 2.183 (95% CI 0.450–10.593) | 0.333 |
| Metastasis at time of surgery | HR 3.397 (95% CI 1.366–8.449) | 0.005 | HR 2.845 (95% CI 0.753–8.199) | 0.135 |
| Pathologic fracture | HR 2.700 (95% CI 1.130–6.452) | 0.025 | HR 2.990 (95% CI 1.099–8.135) | 0.032 |
| Perioperative chemotherapy | HR 1.619 (95% CI 0.711–3.684) | 0.251 | | |
| Perioperative radiotherapy | HR 2.692 (95% CI 1.259–5.756) | 0.011 | HR 2.257 (95% CI 0.928–5.845) | 0.073 |
| Preoperative ANC (below vs above 1000) | HR 0.689 (95% CI 0.093–5.115) | 0.714 | | |
| Preoperative ALC (below vs above 1000) | HR 0.753 (95% CI 0.284–2.001) | 0.570 | | |
| Operative time | HR 1.003 (95% CI 1.00–1.005) | 0.024 | HR 1.002 (95% CI 0.999–1.006) | 0.179 |
| Length of stay | HR 1.069 (95% CI 1.013–1.128) | 0.024 | HR 0.954 (95% CI 0.804–1.131) | 0.587 |
| Postoperative complications | HR 0.758 (95% CI 0.321–1.794) | 0.529 | | |
| Surgical complication within 30 days | HR 2.449 (95% CI 0.575–10.426) | 0.225 | | |
| Return to OR in 30 days | HR 0.049 (95% CI 0.000–2037084.398) | 0.736 | | |
| Reoperation | HR 0.379 (95% CI 0.131–1.094) | 0.073 | | |
|
